RestelliniS Profile Banner
Sophie Restellini Profile
Sophie Restellini

@RestelliniS

Followers
479
Following
2K
Media
40
Statuses
224

Gastroenterologist, Director of the Crohn and Colitis Center of Geneva, Adjunct professor at McGill University Health Center, IBDnet, ECCO, EduCom

Joined April 2019
Don't wanna be here? Send us removal request.
@RestelliniS
Sophie Restellini
3 days
RT @Bealoquebea: Positioning thiopurines in IBD in 2025.Nice talk for a difficult topic by.@RestelliniS at @IBDnet
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
37
0
@RestelliniS
Sophie Restellini
1 month
RT @IBDJournals: What are the risk factors for unplanned 🤰in women with IBD? 🧐. Data from PIANO 🎹 showed ⬆️ risk in women who:.➡️ Face 💰and….
Tweet card summary image
academic.oup.com
Lay Summary. Among pregnant women with IBD, risk factors for unplanned pregnancy from contraceptive failure included low socioeconomic status, low educatio
0
14
0
@RestelliniS
Sophie Restellini
2 months
RT @JulsgaardMette: 🚨Nationwide 🇩🇰study challenges the belief that laparoscopic #IPAA is safer for fertility than open #IPAA in women with….
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Birth rates after laparoscopic and open ileal pouch-anal anastomosis for ulcerative colitis: a nationwide population-based cohort study
0
8
0
@RestelliniS
Sophie Restellini
2 months
RT @JulsgaardMette: 🤱#Upadacitinib detectable in breast milk(n=40) Relative Infant Dose 2.7% (IQR 0.8-10.6) RID ~ #tofacitinib but ⬆️ than….
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Upadacitinib in Mothers With Inflammatory Bowel Disease: Placental Transfer and Breast Milk Excretion
0
22
0
@RestelliniS
Sophie Restellini
2 months
RT @BettenworthDb: What an honor to welcome 🌟 @JeanFredericCo1 to national #IBD meeting in Berlin 🇩🇪! #CED2025.Thank you for sharing your….
0
4
0
@RestelliniS
Sophie Restellini
3 months
💜 May 19: World IBD Day.Today, we stand with everyone affected by Crohn’s disease and ulcerative colitis. These invisible illnesses impact millions, but every story is one of strength and resilience. At the Crohn and Colitis Center of Geneva we’re committed to personalized,
Tweet media one
0
1
11
@RestelliniS
Sophie Restellini
4 months
RT @_MDEducation: Join us in Madrid for the 3rd Annual Women in IBD EU Focus Meeting 2025. Topics will include: .✔️ Global epidemiology….
0
6
0
@RestelliniS
Sophie Restellini
4 months
RT @J_Kirchgesner: 🌟 The #ECCO topical review on IBD Predictive Models has been published in @JCC_IBD! .🔍 In this review, we.1️⃣ Summarized….
0
12
0
@RestelliniS
Sophie Restellini
4 months
Our ECCO topical review on predictive models in IBD is out in JCC!.What exists, how to build them right, and what’s next for clinical impact 🚀 .Check it out: #IBD #ECCO #JCC #PredictiveModels #PrecisionMedicine.@J_Kirchgesner @bverstockt @Iagorlago.
Tweet card summary image
academic.oup.com
AbstractBackground and Aims. Inflammatory bowel disease (IBD) poses a clinical challenge due to its variable progression and treatment response. Despite th
0
14
41
@RestelliniS
Sophie Restellini
4 months
RT @AlaaEl_Hussuna: This review:.1. Identified factors in predicting #IBD progression & treatment response.2. Highlighted barriers to clini….
0
10
0
@RestelliniS
Sophie Restellini
5 months
RT @UmaMahadevanIBD: The @PIANOIBD @HelmsleyTrust Global Consensus patient video now in Portuguese, in addition to Eng, Spanish, French, Ar….
0
12
0
@RestelliniS
Sophie Restellini
6 months
RT @SaraElOualiMD: If you’re an HCP taking care of patients with #IBD please fill out this survey to better understand access to #IBD care….
0
17
0
@RestelliniS
Sophie Restellini
6 months
Bravo @alan_barkun, the best of mentors! .The world needs more Alan Barkun!!Congratulations on this well-deserved recognition!.
@McGillGI
McGill Division of Gastroenterology and Hepatology
6 months
Congratulations to our very own Dr. Alan Barkun for this well deserved award! A mentor and inspiration to so many GI’s across the globe. Thank you Dr. Barkun.for your dedication to improving clinical GI care. @cusm_muhc @alan_barkun
Tweet media one
1
1
4
@RestelliniS
Sophie Restellini
6 months
RT @AlaaEl_Hussuna: Presenting the #ECCO Consensus on Managing IBD in LMICs. 20 dedicated clinicians from #LMICs spent over a year mapping….
0
14
0
@RestelliniS
Sophie Restellini
6 months
Thrilled to have seen our topical review on predictive models in IBD presented at #ECCO2025! This project brought together incredible experts to explore the future of personalized care in IBD. Thanks to everyone involved for their dedication and expertise! #IBD #PredictiveModels
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
9
33
@RestelliniS
Sophie Restellini
6 months
#ECCO2025 has been a fantastic success, with sustainability in IBD at the heart of discussions! 🌱 Honored to have chaired the opening session & contributed to various activities. After 5 years with EpiCom excited now to join EduCom & shape education alongside amazing
Tweet media one
Tweet media two
Tweet media three
5
4
33
@RestelliniS
Sophie Restellini
6 months
RT @BettenworthDb: You are into #IBD, not at the #ECCO congress and have FOMO? 🤔 Well, you may be right. 😉😉.@Y_ECCO_IBD @ibdseb @IBD_FloMD….
0
7
0
@RestelliniS
Sophie Restellini
7 months
RT @DCharabaty: #CCCongress25 Updates in #IBD & #Pregnancy @UmaMahadevanIBD. ⬇️Fertility in women w #IBD:.✔️⬇️Ovarian réserve earlier vs no….
0
13
0